Cardio-renal syndrome: An entity cardiologists and nephrologists should be dealing with collegially

Heart Failure Reviews

Volumn 16, Issue 6, 2011, Pages 503-508

  Palazzuoli, Alberto ^a   Ronco, Claudio ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Biomarkers; Heart failure; Renal insufficiency; Therapy

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; GLYCERYL TRINITRATE; INOTROPIC AGENT; INTERLEUKIN 6; INTERLEUKIN 8; ISTAROXIME; LEVOSIMENDAN; LIPOCALIN; MILRINONE; NESIRITIDE; NITROGEN; RENIN; ROLOFYLLINE; SODIUM; TOLVAPTAN; UREA; VASOPRESSIN; VASOPRESSIN ANTAGONIST;

ARTICLE; CARDIORENAL SYNDROME; CREATININE BLOOD LEVEL; FLUID RETENTION; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART OUTPUT; HEART WORK; HUMAN; HYPOVOLEMIA; KIDNEY BLOOD FLOW; KIDNEY FAILURE; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SODIUM RETENTION; SYMPATHETIC TONE; UREA NITROGEN BLOOD LEVEL; VASOCONSTRICTION; VASODILATATION; VASOPRESSIN RELEASE;

BIOLOGICAL MARKERS; CARDIAC OUTPUT; CARDIO-RENAL SYNDROME; CARDIOVASCULAR AGENTS; DISEASE PROGRESSION; DIURETICS; HEART; HUMANS; INTERDISCIPLINARY COMMUNICATION; KIDNEY; KIDNEY FUNCTION TESTS; MEDICATION THERAPY MANAGEMENT; PATIENT SELECTION; RENAL BLOOD FLOW, EFFECTIVE; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SHOCK; WATER-ELECTROLYTE IMBALANCE;

EID: 80052515667     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-011-9267-x     Document Type: Article

References (48)

1. GL Smith JH Lichtman MB Bracken MG Shlipak CO Phillips P DiCapua HM Krumholz 2006 Renal impairment and outcomes in heart failure systematic review and meta-analysis J Am Coll Cardiol 47 1987 1996 16697315 10.1016/j.jacc.2005. 11.084
2. A Nohria V Hasselblad A Strebbin, et al. 2008 Cardio-renal interactions: insight from the ESCAPE trial J Am Coll Cardiol 51 1268 1274 18371557 10.1016/j.jacc.2007.08.072 (Pubitemid 351400890)
3. KV Liang AW Williams EL Greene MM Redfield 2008 Acute decompensated heart failure and the cardiorenal syndrome Crit Care Med 36 S75 S88 18158481 10.1097/01.CCM.0000296270.41256.5C
4. C Ronco M Haapio AA House N Anavekar R Bellomo 2008 Cardiorenal syndrome J Am Coll Cardiol 52 1527 1529 19007588 10.1016/j.jacc.2008.07.051
5. T Berl W Henrich 2006 Kidney-heart interactions: epidemiology, pathogenesis, and treatment Clin J Am Soc Nephrol 1 8 18 17699186 10.2215/CJN.00730805 1:CAS:528:DC%2BD28XjvV2hu7s%3D
6. HL Hillege AR Girbes PJ de Kam, et al. 2000 Renal function, neurohormonal activation and survival in patients with chronic heart failure Circulation 102 203 210 10889132 1:STN:280:DC%2BD3czkvFeqtQ%3D%3D (Pubitemid 30451778)
7. J Ezekowitz FA McAlister KH Humphries, et al. 2004 The association among renal insufficiency, pharmacoteraphy and outcome in 6,427 patients with heart failure and coronary artery disease J Am Coll Cardiol 44 1587 1592 15489090 10.1016/j.jacc.2004.06.072 (Pubitemid 39369790)
8. HE Saltzman K Sharma PJ Mather S Rubin S Adams DJ Whellan 2007 Renal dysfunction in heart failure patients: what is the evidence? Heart Fail Rev 12 37 47 17393304 10.1007/s10741-007-9006-5 (Pubitemid 46629245)
9. GC Fonarow KF Adams WT Abraham CW Yancy WJ Boscardin for The ADHERE scientific advisory committee study group and Investigators, et al. 2005 Risk stratification for in hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 572 580 15687312 10.1001/jama.293.5.572 1:CAS:528:DC%2BD2MXhtVWqsLg%3D (Pubitemid 40171239)
10. W Mullens Z Abrahams GS Francis G Sokos, et al. 2009 Importance of venous congestion for worsening renal function in advanced decompensated heart failure J Am Coll Cardiol 53 589 596 19215833 10.1016/j.jacc.2008.05.068
11. K Damman G Navis AA Voors FW Asselbergs, et al. 2007 Worsening renal function and prognosis in heart failure: a systematic review and meta-analysis J Cardiac Fail 13 599 608 10.1016/j.cardfail.2007.04.008 (Pubitemid 47513536)
12. HM Krumholz YT Chen V Vaccarino, et al. 2000 Correlates and impact on outcomes of worsening renal function in patients >65 years of age with heart failure Am J Cardiol 85 1110 1113 10781761 10.1016/S0002-9149(00)00705-0 1:STN:280:DC%2BD3c3ksFSksg%3D%3D (Pubitemid 30214258)
13. GL Smith V Vaccarino M Kosiborod, et al. 2003 Worsening renal function: what is the clinical meaningful change in creatinine during hospitalization with heart failure? J Cardiac Fail 9 13 25 10.1054/jcaf.2003.3 1:CAS:528: DC%2BD3sXhvFekt7g%3D (Pubitemid 36356697)
14. DL Dries DV Exner MJ Domanski, et al. 2000 The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction J Am Coll Cardiol 35 681 689 10716471 10.1016/S0735-1097(99)00608-7 1:STN:280:DC%2BD3c7nvFaitw%3D%3D (Pubitemid 30167025)
15. HL Hillege D Nitsch MA Pfeffer K Swedberg, et al. 2006 Renal Function as a predictor of outcome in a broad spectrum of patients with heart failure Circulation 113 671 678 16461840 10.1161/CIRCULATIONAHA.105.580506
16. HM Krumolz YT Chen Y Wang V Vaccarino MJ Radford RI Horwitz 2000 Predictors of readmission among elderly survivors of admission with heart failure Am Heart J 139 72 77 10.1016/S0002-8703(00)90311-9 (Pubitemid 30043627)
17. L Klein BM Massie D Leimberger, et al. 2008 Admission or changes in renal function during hospitalization for worsening heart failure predict post discharge survival Cir Heart Fail 1 25 33 10.1161/CIRCHEARTFAILURE.107.746933 1:CAS:528:DC%2BD1cXosFGnsLc%3D
18. CJ Petrie PB Mark R Weir 2008 Broken pump or leaky filter? Renal dysfunction in heart failure a contemporary review Int J Cardiol 128 154 165 18191240 10.1016/j.ijcard.2007.12.016
19. UC Brewster JF Setaro MA Perazella 2003 The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states Am J Med Sci 326 15 24 12861121 10.1097/00000441-200307000-00003 (Pubitemid 36870293)
20. JA Joles HA Koomans 2004 Causes and consequences of increased sympathetic activity in renal disease Hypertension 43 699 706 14981063 10.1161/01.HYP. 0000121881.77212.b1 1:CAS:528:DC%2BD2cXit12msb0%3D (Pubitemid 38405571)
21. S Ljungman JH Laragh RJ Cody 1990 Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function Drugs 39 suppl 4 10 21 2354670 10.2165/00003495-199000394-00004 (Pubitemid 20182861)
22. RW Schrier 2006 Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 47 1 8 16386657 10.1016/j.jacc.2005.07.067 (Pubitemid 43005157)
23. JF Firth AE Raine JG Ledingham 1988 Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet 1 1033 1035 2896877 10.1016/S0140-6736(88)91851-X 1:STN:280:DyaL1c3hsFOhug%3D%3D
24. M Jessup MR Costanzo 2009 The cardiorenal syndrome do we need a change of strategy of a change of tactics? J Am Coll Cardiol 53 597 599 19215834 10.1016/j.jacc.2008.11.012
25. EL Schiffrin ML Lipman JFE Mann 2007 Chronic kidney disease effects on the cardiovascular system Circulation 116 85 97 17606856 10.1161/CIRCULATIONAHA. 106.678342 (Pubitemid 47016250)
26. M Sigrist P Bungay MW Taal CW Mc Intyre 2006 Vascular calcification and cardiovascular function in chronic kidney disease Nephrol Dial Transplant 21 707 714 16263735 10.1093/ndt/gfi236 (Pubitemid 43372919)
27. M Gheorghiade PS Pang 2009 Acute heart failure syndromes J Am Coll Cardiol 53 557 573 19215829 10.1016/j.jacc.2008.10.041
28. L Tavazzi AP Maggioni D Lucci G Cacciatore G Ansalone F Oliva M Porcu 2006 Nationwide survey on acute heart failure in cardiology ward services in Italy Eur H J 27 1207 1215 10.1093/eurheartj/ehi845
29. 2009 Focused Update: ACCF/AHA Guidelines for the diagnosis and management of heart failure in adults: a report of the American college of cardiology foundation/America heart association task force on practice guidelines: developed in collaboration with the international society of heart and lung transplantation. 2009;119:1977-2016
30. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur H J 2008; 29: 2388-2442
31. GS Francis RM Siegel SR Goldsmith MT Olivari TB Levine JN Cohn 1985 Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure: activation of the neurohumoral axis Ann Intern Med 103 1 6 2860833 1:STN:280:DyaL2M3itlCrsA%3D%3D (Pubitemid 15068490)
32. M Domanski J Norman B Pitt M Haigney S Hanlon E Peyster 2003 Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD) J Am Coll Cardiol 42 705 708 12932605 10.1016/S0735-1097(03)00765-4 1:CAS:528:DC%2BD3sXnsFerurY%3D (Pubitemid 37000189)
33. Abraham WT, Adams KF, Fonarow GC, et al., for the ADHERE Scientific Advisory Committee and Investigators and the ADHERE Study Group (2005) In-hospital mortality in patients with acute decompensated heart failure treated with intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 46:57-64 (Pubitemid 40905130)
34. Elkayam U, Tasissa G, Binanay C et al. (2004) Use and impact of inotropes and vasodilator therapy during heart failure hospitalization in the ESCAPE Trial. Circulation 110(suppl 3):III-515. Abstract 2415
35. A Mebazaa MS Nieminem M Packer A Cohen-Solal FX Kleber R Pocock Thakkar J Padley P Poder M Kivikko 2007 Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial JAMA 297 1883 1891 17473298 10.1001/jama.297.17.1883 1:CAS:528:DC%2BD2sXkvFKrsLs%3D (Pubitemid 46707842)
36. M Packer WH Lee PD Kessler SS Gottlieb N Medina M Yushak 1987 Prevention and reversal of nitrate tolerance in patients with congestive heart failure N Engl J Med 317 799 804 3114637 10.1056/NEJM198709243171304 1:STN:280: DyaL2szhsFanug%3D%3D (Pubitemid 17136471)
37. D Wang TC Dowling D Meadows T Ayala, et al. 2004 Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine Circulation 110 1620 1625 15337695 10.1161/01.CIR.0000141829. 04031.25 1:CAS:528:DC%2BD2cXnsVKqur8%3D (Pubitemid 39297985)
38. TE Owan HH Chen RP Frantz BL Karon, et al. 2008 The effect of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction J Card Fail 14 267 275 18474338 10.1016/j.cardfail.2007.12.002 1:CAS:528:DC%2BD1cXlvVSltL8%3D (Pubitemid 351636237)
39. AF Hernandez CM O'Connor RC Starling CJ Reist PW Armstrong, et al. 2009 Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF) Am Heart J 157 271 277 19185633 10.1016/j.ahj.2008.07.031 1:CAS:528:DC%2BD1MXhtlSktrY%3D
40. M Gheorghiade JE Blair GS Filippatos C Macarie W Ruzyllo, et al. 2008 Hemodynamic Echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized trial in patients hospitalized for heart failure HORIZON-HF J Am Coll Cardiol 51 2276 2285 18534276 10.1016/j.jacc.2008.03.015 1:CAS:528:DC%2BD1cXmvVOgsLo%3D
41. T Dschietzig SL Teichman E Unemori, et al. 2009 Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability and pharmacodynamic trial J Cardiac Fail 15 182 190 10.1016/j.cardfail.2009.01.008 1:CAS:528:DC%2BD1MXjvVaht7c%3D
42. JR Teerlink M Metra GM Felker P Ponikowski AA Voors 2009 Relaxin for the treatment of patients with acute heart failure (pre RELAX-HF): a multicenter randomized placebo controlled parallel group dose-finding phase IIb study Lancet 373 1429 1439 19329178 10.1016/S0140-6736(09)60622-X 1:CAS:528: DC%2BD1MXltVCqtbk%3D
43. G Cotter HC Dittrich BE Weatherley DM Bloomfield, et al. 2008 The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment J Card Fail 14 631 640 18926433 10.1016/j.cardfail.2008.08.010 1:CAS:528:DC%2BD1cXhtFOrtLvK
44. MM Givertz BM Massie TK Fields LL Pearson, et al. 2007 The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance J Am Coll Cardiol 50 1551 1560 17936154 10.1016/j.jacc.2007.07.019 1:CAS:528:DC%2BD2sXhtFKisLnE (Pubitemid 47532320)
45. BM Massie CF O'Connor M Metra P Ponikowski JR Teerlink G Cotter BD Weatherley JG Cleland MM Givertz A Voors P DeLucca GA Mansoor CM Salerno DM Bloomfield HC Dittrich 2010 Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure N Engl Med J 363 1419 1428 10.1056/NEJMoa0912613
46. MA Konstam M Gheorghiade JC Burnett Jr L Grinfeld AP Maggioni 2007 Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial JAMA 297 1319 1328 17384437 10.1001/jama.297.12.1319 1:CAS:528:DC%2BD2sXjs1ejtrg%3D (Pubitemid 46513233)
47. MR Costanzo ME Guglin MT Saltzberg ML Jessup BA Bart, et al. 2007 Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure J Am Coll Cardiol 49 675 683 17291932 10.1016/j.jacc.2006.07.073 1:CAS:528:DC%2BD2sXhs1Slt7g%3D (Pubitemid 46205043)
48. CY Goh G Virzì M De Cal 2011 Ronco C: cardiorenal syndrome: a complex series of combined heart/kidney disorders Contrib Nephrol 174 1 13